Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab‐induced arthritis by methylprednisolone, baricitinib, and remdesivir

COVID‐19 in cancer patients on immunosuppressive agents for the treatment of immune‐related adverse events of immune checkpoint inhibitors can rapidly deteriorate. The combination therapy with methylprednisolone, baricitinib, and remdesivir may be effective for critical COVID‐19, and further clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Oda, Naohiro, Miyoshi, Keiji, Morichika, Daisuke, Beika, Yuka, Taki, Takahiro, Mitani, Reo, Okada, Toshiaki, Takata, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259795/
https://www.ncbi.nlm.nih.gov/pubmed/34257986
http://dx.doi.org/10.1002/ccr3.4459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259795/
https://www.ncbi.nlm.nih.gov/pubmed/34257986
http://dx.doi.org/10.1002/ccr3.4459

Ejemplares similares